Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-24 @ 3:22 PM
NCT ID:
NCT00002292
Eligibility Criteria:
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
* Previous history of adverse reaction to pentamidine.
* History of asthma.
* Pulmonary Kaposi's sarcoma.
Patients with the following are excluded:
* Previous history of adverse reaction to pentamidine.
* History of asthma.
* Pulmonary Kaposi's sarcoma.
* Inability to understand the consent procedure.
All patients hospitalized at Cedars-Sinai Medical Center with AIDS and possible Pneumocystis carinii pneumonia (PCP) will be eligible.
* Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are eligible.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002292
Study Brief:
Protocol Section:
NCT00002292